Apolipoprotein E, Alcohol Consumption, and Risk of Ischemic Stroke: The Framingham Heart Study Revisited

Journal of Stroke and Cerebrovascular Diseases

Volumn 18, Issue 5, 2009, Pages 384-388

  Djoussé, Luc ^a   Himali, Jayandra J ^b,c   Beiser, Alexa ^b,c,d   Kelly Hayes, Margaret ^c,d   Wolf, Philip A ^c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol drinking; apolipoprotein E gene; ischemic stroke; lipids

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE EXPRESSION; HAZARD RATIO; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

AGED; AGED, 80 AND OVER; ALCOHOL DRINKING; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN ISCHEMIA; CHOLESTEROL, HDL; COHORT STUDIES; COMORBIDITY; DNA MUTATIONAL ANALYSIS; ETHANOL; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; LONGITUDINAL STUDIES; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE;

EID: 69149089638     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2009.01.008     Document Type: Article

References (35)

1. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 117 (2008) e25-146
2. Carandang R., Seshadri S., Beiser A., et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA 296 (2006) 2939-2946
3. Taylor T.N., Davis P.H., Torner J.C., et al. Lifetime cost of stroke in the United States. Stroke 27 (1996) 1459-1466
4. Diringer M.N., Edwards D.F., Mattson D.T., et al. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke 30 (1999) 724-728
5. Djousse L., Ellison R.C., Beiser A., et al. Alcohol consumption and risk of ischemic stroke: The Framingham study. Stroke 33 (2002) 907-912
6. Daniel S., and Bereczki D. Alcohol as a risk factor for hemorrhagic stroke. Ideggyogyaszati Szemle 57 (2004) 247-256
7. Reynolds K., Lewis B., Nolen J.D., et al. Alcohol consumption and risk of stroke: A meta-analysis. JAMA 289 (2003) 579-588
8. Gaziano J.M., Buring J.E., Breslow J.L., et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 329 (1993) 1829-1834
9. Sacanella E., Vazquez-Agell M., Mena M.P., et al. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: A randomized trial. Am J Clin Nutr 86 (2007) 1463-1469
10. Covas M.I., Konstantinidou V., Mysytaki E., et al. Postprandial effects of wine consumption on lipids and oxidative stress biomarkers. Drugs Exp Clin Res 29 (2003) 217-223
11. Sierksma A., van der Gaag M.S., Kluft C., et al. Moderate alcohol consumption reduces plasma C-reactive protein and fibrinogen levels; a randomized, diet-controlled intervention study. Eur J Clin Nutr 56 (2002) 1130-1136
12. Stewart S.H. Alcohol and inflammation: A possible mechanism for protection against ischemic heart disease. Nutr Metab Cardiovasc Dis 12 (2002) 148-151
13. Rimm E.B., Williams P., Fosher K., et al. Moderate alcohol intake and lower risk of coronary heart disease: Meta-analysis of effects on lipids and hemostatic factors. BMJ 319 (1999) 1523-1528
14. Wilson P.W., Schaefer E.J., Larson M.G., et al. Apolipoprotein E alleles and risk of coronary disease: A meta-analysis. Arterioscler Thromb Vasc Biol 16 (1996) 1250-1255
15. Tiret L., de Knijff P., Menzel H.J., et al. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: The EARS study (European atherosclerosis research study). Arterioscler Thromb 14 (1994) 1617-1624
16. Woo D., Kaushal R., Chakraborty R., et al. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke 36 (2005) 1874-1879
17. Souza D.R., Campos B.F., Arruda E.F., et al. Influence of the polymorphism of apolipoprotein E in cerebral vascular disease. Arq Neuropsiquiatr 61 (2003) 7-13
18. Ferrucci L., Guralnik J.M., Pahor M., et al. Apolipoprotein E epsilon 2 allele and risk of stroke in the older population. Stroke 28 (1997) 2410-2416
19. Farrer L.A., Cupples L.A., Kukill W.A., et al. Risk of Alzheimer disease is associated with parental age among apolipoprotein E 4 heterozygotes. Alzheimer Res 3 (1997) 83-91
20. Harwood D.G., Barker W.W., Ownby R.L., et al. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample. Int Psychogeriatr 16 (2004) 317-326
21. Olarte L., Schupf N., Lee J.H., et al. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics. Arch Neurol 63 (2006) 1586-1590
22. Djousse L., Pankow J.S., Arnett D.K., et al. Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung, and Blood Institute family heart study. Am J Clin Nutr 80 (2004) 1639-1644
23. Dawber T.R., Kannel W.B., McNamara P.M., et al. An epidemiologic study of apoplexy ("strokes"): Observations in 5,209 adults in the Framingham study on association of various factors in the development of apoplexy. Trans Am Neurol Assoc 90 (1965) 237-240
24. Kannel W.B., Feinleib M., McNamara P.M., et al. An investigation of coronary heart disease in families: The Framingham offspring study. Am J Epidemiol 110 (1979) 281-290
25. Djousse L., Dorgan J.F., Zhang Y., et al. Alcohol consumption and risk of lung cancer: The Framingham Study. J Natl Cancer Inst 94 (2002) 1877-1882
26. Djousse L., Levy D., Benjamin E.J., et al. Long-term alcohol consumption and the risk of atrial fibrillation: The Framingham study. Am J Cardiol 93 (2004) 710-713
27. Wolf P.A., D'Agostino R.B., Belanger A.J., et al. Probability of stroke: A risk profile from the Framingham study. Stroke 22 (1991) 312-318
28. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 (1990) 545-548
29. Warnick G.R., Benderson J., and Albers J.J. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28 (1982) 1379-1388
30. Lipid Research Clinics Program. Manual of laboratory and operations, Vol 1: Lipid and lipoprotein analysis. DHEW publication No. (National Institutes of Health) 75-628 (1974), National Institutes of Health, Bethesda, MD
31. Beulens J.W., van Loon L.J., Kok F.J., et al. The effect of moderate alcohol consumption on adiponectin oligomers and muscle oxidative capacity: A human intervention study. Diabetologia 50 (2007) 1388-1392
32. Davies M.J., Baer D.J., Judd J.T., et al. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: A randomized controlled trial. JAMA 287 (2002) 2559-2562
33. Beulens J.W., de Zoete E.C., Kok F.J., et al. Effect of moderate alcohol consumption on adipokines and insulin sensitivity in lean and overweight men: A diet intervention study. Eur J Clin Nutr 62 (2007) 1098-1105
34. Sierksma A., Patel H., Ouchi N., et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-alpha, and insulin sensitivity. Diabetes Care 27 (2004) 184-189
35. Djousse L., Biggs M.L., Mukamal K.J., et al. Alcohol consumption and type 2 diabetes among older adults: The cardiovascular health study. Obesity 15 (2007) 1758-1765